# Study to Assess Pharmacokinetic (PK), Bioavailability & Food Effect of MR902 Compared With Immediate Release (IR) Morphine Sulphate Oral Solution

> **NCT02773316** · PHASE1 · COMPLETED · sponsor: **Mundipharma Research Limited** · enrollment: 84 (actual)

## Conditions studied

- Opioid Substitution Treatment

## Interventions

- **DRUG:** MR902
- **DRUG:** IR morphine sulphate

## Key facts

- **NCT ID:** NCT02773316
- **Lead sponsor:** Mundipharma Research Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2016-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02773316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02773316, "Study to Assess Pharmacokinetic (PK), Bioavailability & Food Effect of MR902 Compared With Immediate Release (IR) Morphine Sulphate Oral Solution". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02773316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*